| BAI | basilar artery insufficiency; beta-aminoisobutyrate |
|---|---|
| BAIB | beta-aminoisobutyric [acid] |
| BAP | bacterial alkaline phosphatase; Behavior Activity Profile; beta-amyloid peptide; blood-agar plate; b... |
| BAPN | beta-aminoproprionitrile fumarate |
| BAPP | beta amyloid precursor protein |
| 3 beta-HSD | 3 beta-Hydroxysteroid dehydrogenasel delta 5-->4-isomerase |
|---|---|
| 3 beta-HSD | 3 beta-hydroxy-steroid dehydrogenase/delta 5-delta 4 isomerase |
| 3 beta-HSDH | 3 beta-hydroxysteroid dehydrogenase |
| 4 beta-PMA | 4 beta-Phorbol 12-myristate 13-acetate |
| 4 beta-PDB | 4 beta-phorbol 12, 13-dibutyrate |
| insulin pump | A device that delivers a continuous supply of insulin into the body. The insulin flows from the pump through a plastic tube that is connected to a needle inserted into the body and taped in place. Insulin is delivered at two rates: a low, steady rate (called the basal rate) for continuous day-long coverage, and extra boosts of insulin (called bolus doses) to cover meals or when extra insulin is needed. The pump runs on batteries and can be worn clipped to a belt or carried in a pocket. It is used by people with insulin-dependent diabetes. (09 Oct 1997) |
|---|---|
| insulin reaction | A sudden uncontrolled decline in the blood sugar due to effects of insulin. (27 Sep 1997) |
| insulin receptor | Areas on the outer part of a cell that allow the cell to join or bind with insulin that is in the blood. When the cell and insulin bind together, the cell can take glucose (sugar) from the blood and use it for energy. (09 Oct 1997) |
| insulin receptor protein-tyrosine kinase | <enzyme> A catalytic protein-tyrosine kinase domain found on the cytoplasmic beta-portion of the insulin receptor. Registry number: EC 2.7.1.- (12 Dec 1998) |
| insulin receptor substrate-1 protein | <chemical> Amino acid sequence given in first source; a 180 kD protein that contains multiple phosphorylated tyrosine residues after insulin stimulation; human and rat forms (hirs-1 and irs-1) are homologous Synonym: insulin receptor substrate-1-like protein, irs-1 protein, irs-1 gene product, hirs-1 protein, hirs-1 gene product, insulin receptor substrate 1, insulin receptor substrate-1 (05 Dec 1998) |
| insulin resistance | Many people with noninsulin-dependent diabetes produce enough insulin, but their bodies do not respond to the action of insulin. This may happen because the person is overweight and has too many fat cells, which do not respond well to insulin. Also, as people age, their body cells lose some of the ability to respond to insulin. Insulin resistance is also linked to high blood pressure and high levels of fat in the blood. Another kind of insulin resistance may happen in some people who take insulin injections. They may have to take very high doses of insulin every day (200 units or more) to bring their blood glucose (sugar) down to the normal range. (09 Oct 1997) |
| insulin shock | A severe condition that occurs when the level of blood glucose (sugar) drops quickly. The signs are shaking, sweating, dizziness, double vision, convulsions, and collapse. Insulin shock may occur when an insulin reaction is not treated quickly enough. See: hypoglycaemia. (09 Oct 1997) |
| insulin shock treatment | Formerly used treatment for serious mental disorders in which the patient was given insulin to induce a seizure; supplanted by electroshock therapy. (05 Mar 2000) |
| insulin-stimulating peptide | <chemical> 71-amino acid containing peptide; corresponds to residues 115-143 and 144-184 of bovine serum albumin with the exception of a tyrosine insertion between residues 155 and 156; consists of two chains with mw 5000 and 3400 for each chain Synonym: h-isp, insulin-stimulating protein (05 Dec 1998) |
| insulin unit | The activity contained in 1/22 mg of the international standard of zinc-insulin crystals. (05 Mar 2000) |
| insulin zinc suspension | A sterile buffered suspension with zinc chloride, containing 40 or 80 units per ml; the solid phase of the suspension consists of a mixture of 7 parts of crystalline insulin and 3 parts of amorphous insulin. Synonym: lente insulin. (05 Mar 2000) |
| extended insulin zinc suspension | A long-acting insulin suspension, obtained from beef, with an approximate time of onset of 7 hours and a duration of action of 36 hours. Synonym: crystalline insulin zinc suspension. (05 Mar 2000) |
| ultralente insulin | A form of zinc precipitated insulin in suspension in which the particle size is large, and thus release into the bloodstream after subcutaneous injection is slow; it can be mixed with other insulins having different particle sizes to achieve different durations of activity. Can be derived from porcine, bovine, or genetically engineered human type. (05 Mar 2000) |
| lente insulin | A sterile buffered suspension with zinc chloride, containing 40 or 80 units per ml; the solid phase of the suspension consists of a mixture of 7 parts of crystalline insulin and 3 parts of amorphous insulin. Synonym: lente insulin. (05 Mar 2000) |
| beta cell | 1. <pathology> Cells of the pancreas within discrete endocrine islands (Islets of Langerhans) embedded in the major exocrine tissue of vertebrate pancreas. The B or beta cells (originally distinguished by differential staining from A, C and D), are responsible for synthesis and secretion of insulin, a hormone that controls the level of glucosein the blood. 2. Also refers to the beta cells of the anterior lobe of hypophysis. These are a population of functionally diverse cell's that contain basophilic granules and secrete hormones such as ACTH, lipotropin, thyrotropin, and the gonadotropins. Synonym: basophil cell of anterior lobe of hypophysis. (05 Mar 2000) |